Role of lipids in the metabolism and activation of immune cells

Journal of Nutritional Biochemistry

Volumn 34, Issue , 2016, Pages 1-7

  Hubler, Merla J ^a   Kennedy, Arion J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fatty acids; Inflammation; Macrophages; Oxysterols; T lymphocytes

Indexed keywords

CHOLESTEROL; CONJUGATED LINOLEIC ACID; LIPID; OXYSTEROL; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN;

ADAPTIVE IMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PLASTICITY; CELL PROLIFERATION; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; LIPID HOMEOSTASIS; LIPID METABOLISM; LIPOGENESIS; LYMPHOCYTE ACTIVATION; MACROPHAGE; METABOLIC DISORDER; NONHUMAN; PHENOTYPE; REVIEW; T LYMPHOCYTE ACTIVATION; BIOLOGICAL MODEL; CARDIOVASCULAR DISEASE; CELLULAR IMMUNITY; CYTOLOGY; FAT INTAKE; IMMUNOLOGY; METABOLISM; NONALCOHOLIC FATTY LIVER; NUTRITIONAL STATUS; OBESITY; PATHOLOGY; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; CARDIOVASCULAR DISEASES; CELL PLASTICITY; DIETARY FATS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; LIPID METABOLISM; MACROPHAGES; MODELS, IMMUNOLOGICAL; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITIONAL STATUS; OBESITY; T-LYMPHOCYTES;

EID: 84961159913     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.11.002     Document Type: Review

References (86)

1. Kratz M., Coats B.R., Hisert K.B., Hagman D., Mutskov V., Peris E., et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell Metab 2014, 20:614-625.
2. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol 2010, 11:889-896.
3. Zhang N., Bevan M.J. CD8(+) T cells: foot soldiers of the immune system. Immunity 2011, 35:161-168.
4. Zhu J., Yamane H., Paul W.E. Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 2010, 28:445-489.
5. Chaudhry A., Rudra D., Treuting P., Samstein R.M., Liang Y., Kas A., et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009, 326:986-991.
6. Wohlfert E.A., Grainger J.R., Bouladoux N., Konkel J.E., Oldenhove G., Ribeiro C.H., et al. GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice. J Clin Invest 2011, 121:4503-4515.
7. Stewart C.A., Metheny H., Iida N., Smith L., Hanson M., Steinhagen F., et al. Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation. J Clin Invest 2013, 123:4859-4874.
8. Josefowicz S.Z., Lu L.F., Rudensky A.Y. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012, 30:531-564.
9. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007, 117:175-184.
10. Martinez F.O., Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime Rep 2014, 6:13.
11. Kinoshita M., Uchida T., Sato A., Nakashima M., Nakashima H., Shono S., et al. Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice. J Hepatol 2010, 53:903-910.
12. Zigmond E., Samia-Grinberg S., Pasmanik-Chor M., Brazowski E., Shibolet O., Halpern Z., et al. Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury. J Immunol 2014, 193:344-353.
13. Obstfeld A.E., Sugaru E., Thearle M., Francisco A.M., Gayet C., Ginsberg H.N., et al. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis. Diabetes 2010, 59:916-925.
14. Tacke F., Zimmermann H.W. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol 2014, 60:1090-1096.
15. Deng Z.B., Liu Y., Liu C., Xiang X., Wang J., Cheng Z., et al. Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology 2009, 50:1412-1420.
16. Tacke F., Randolph G.J. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006, 211:609-618.
17. Gui T., Shimokado A., Sun Y., Akasaka T., Muragaki Y. Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discovery. Mediat Inflamm 2012, 2012:693083.
18. Moore K.J., Sheedy F.J., Fisher E.A. Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 2013, 13:709-721.
19. Ley K., Miller Y.I., Hedrick C.C. Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol 2011, 31:1506-1516.
20. Stoger J.L., Gijbels M.J., van der Velden S., Manca M., van der Loos C.M., Biessen E.A., et al. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 2012, 225:461-468.
21. Thorp E., Tabas I. Mechanisms and consequences of efferocytosis in advanced atherosclerosis. J Leukoc Biol 2009, 86:1089-1095.
22. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010, 10:36-46.
23. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009, 15:921-929.
24. Madhur M.S., Lob H.E., McCann L.A., Iwakura Y., Blinder Y., Guzik T.J., et al. Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010, 55:500-507.
25. Brand S. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009, 58:1152-1167.
26. Ye L., Jiang B., Deng J., Du J., Xiong W., Guan Y., et al. IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting Th17 cell proliferation. J Immunol 2015, 194:5110-5119.
27. Bieghs V., Hendrikx T., van Gorp P.J., Verheyen F., Guichot Y.D., Walenbergh S.M., et al. The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice. Gastroenterology 2013, 144:167-178.e1.
28. Hendrikx T., Jeurissen M.L., Bieghs V., Walenbergh S.M., van Gorp P.J., Verheyen F., et al. Hematopoietic overexpression of Cyp27a1 reduces hepatic inflammation independently of 27-hydroxycholesterol levels in Ldlr(-/-) mice. J Hepatol 2015, 62:430-436.
29. Brown A.J., Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999, 142:1-28.
30. Umetani M., Ghosh P., Ishikawa T., Umetani J., Ahmed M., Mineo C., et al. The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha. Cell Metab 2014, 20:172-182.
31. Spann N.J., Garmire L.X., McDonald J.G., Myers D.S., Milne S.B., Shibata N., et al. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 2012, 151:138-152.
32. Rodriguez-Acebes S., de la Cueva P., Fernandez-Hernando C., Ferruelo A.J., Lasuncion M.A., Rawson R.B., et al. Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line. Biochem J 2009, 420:305-315.
33. Yang C., McDonald J.G., Patel A., Zhang Y., Umetani M., Xu F., et al. Sterol intermediates from cholesterol biosynthetic pathway as liver X receptor ligands. J Biol Chem 2006, 281:27816-27826.
34. Casella C., Miller D.H., Lynch K., Brodsky A.S. Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells. Gynecol Oncol 2014, 135:333-341.
35. Allen A.M., Taylor J.M., Graham A. Mitochondrial (dys)function and regulation of macrophage cholesterol efflux. Clin Sci 2013, 124:509-515.
36. Soroosh P., Wu J., Xue X., Song J., Sutton S.W., Sablad M., et al. Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation. Proc Natl Acad Sci U S A 2014, 111:12163-12168.
37. Cnop M., Igoillo-Esteve M., Cunha D.A., Ladriere L., Eizirik D.L. An update on lipotoxic endoplasmic reticulum stress in pancreatic beta-cells. Biochem Soc Trans 2008, 36:909-915.
38. Cnop M. Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes. Biochem Soc Trans 2008, 36:348-352.
39. Galgani J.E., Uauy R.D., Aguirre C.A., Diaz E.O. Effect of the dietary fat quality on insulin sensitivity. Br J Nutr 2008, 100:471-479.
40. Kien C.L., Bunn J.Y. Gender alters the effects of palmitate and oleate on fat oxidation and energy expenditure. Obesity 2008, 16:29-33.
41. Kennedy A., Martinez K., Chuang C.C., LaPoint K., McIntosh M. Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. J Nutr 2009, 139:1-4.
42. Anderson E.K., Hill A.A., Hasty A.H. Stearic acid accumulation in macrophages induces toll-like receptor 4/2-independent inflammation leading to endoplasmic reticulum stress-mediated apoptosis. Arterioscler Thromb Vasc Biol 2012, 32:1687-1695.
43. Leroux A., Ferrere G., Godie V., Cailleux F., Renoud M.L., Gaudin F., et al. Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis. J Hepatol 2012, 57:141-149.
44. Penzo D., Tagliapietra C., Colonna R., Petronilli V., Bernardi P. Effects of fatty acids on mitochondria: implications for cell death. Biochim Biophys Acta 2002, 1555:160-165.
45. Freigang S., Ampenberger F., Weiss A., Kanneganti T.D., Iwakura Y., Hersberger M., et al. Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1alpha and sterile vascular inflammation in atherosclerosis. Nat Immunol 2013, 14:1045-1053.
46. Stentz F.B., Kitabchi A.E. Palmitic acid-induced activation of human T-lymphocytes and aortic endothelial cells with production of insulin receptors, reactive oxygen species, cytokines, and lipid peroxidation. Biochem Biophys Res Commun 2006, 346:721-726.
47. de Jong A.J., Kloppenburg M., Toes R.E., Ioan-Facsinay A. Fatty acids, lipid mediators, and T-cell function. Front Immunol 2014, 5:483.
48. Smith M.I., Yatsunenko T., Manary M.J., Trehan I., Mkakosya R., Cheng J., et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science 2013, 339:548-554.
49. Park J., Kim M., Kang S.G., Jannasch A.H., Cooper B., Patterson J., et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol 2015, 8:80-93.
50. Maslowski K.M., Vieira A.T., Ng A., Kranich J., Sierro F., Yu D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-1286.
51. Kim M.H., Kang S.G., Park J.H., Yanagisawa M., Kim C.H. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 2013, 145:396-406.e1-10.
52. Zhao G., Etherton T.D., Martin K.R., Vanden Heuvel J.P., Gillies P.J., West S.G., et al. Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochem Biophys Res Commun 2005, 336:909-917.
53. Oliver E., McGillicuddy F.C., Harford K.A., Reynolds C.M., Phillips C.M., Ferguson J.F., et al. Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. J Nutr Biochem 2012, 23:1192-1200.
54. Itoh T., Fairall L., Amin K., Inaba Y., Szanto A., Balint B.L., et al. Structural basis for the activation of PPARgamma by oxidized fatty acids. Nat Struct Mol Biol 2008, 15:924-931.
55. Xue B., Yang Z., Wang X., Shi H. Omega-3 polyunsaturated fatty acids antagonize macrophage inflammation via activation of AMPK/SIRT1 pathway. PLoS One 2012, 7:e45990.
56. Kennedy A., Martinez K., Schmidt S., Mandrup S., LaPoint K., McIntosh M. Antiobesity mechanisms of action of conjugated linoleic acid. J Nutr Biochem 2010, 21:171-179.
57. Draper E., DeCourcey J., Higgins S.C., Canavan M., McEvoy F., Lynch M., et al. Conjugated linoleic acid suppresses dendritic cell activation and subsequent Th17 responses. J Nutr Biochem 2014, 25:741-749.
58. Wang H., Hao Q., Li Q.R., Yan X.W., Ye S., Li Y.S., et al. Omega-3 polyunsaturated fatty acids affect lipopolysaccharide-induced maturation of dendritic cells through mitogen-activated protein kinases p38. Nutrition 2007, 23:474-482.
59. Yessoufou A., Ple A., Moutairou K., Hichami A., Khan N.A. Docosahexaenoic acid reduces suppressive and migratory functions of CD4+CD25+ regulatory T-cells. J Lipid Res 2009, 50:2377-2388.
60. Collison L.W., Collison R.E., Murphy E.J., Jolly C.A. Dietary n-3 polyunsaturated fatty acids increase T-lymphocyte phospholipid mass and acyl-CoA binding protein expression. Lipids 2005, 40:81-87.
61. Santos V.C., Levada-Pires A.C., Alves S.R., Pithon-Curi T.C., Curi R., Cury-Boaventura M.F. Effects of DHA-rich fish oil supplementation on lymphocyte function before and after a marathon race. Int J Sport Nutr Exerc Metab 2013, 23:161-169.
62. Kim H.J., Vosseler C.A., Weber P.C., Erl W. Docosahexaenoic acid induces apoptosis in proliferating human endothelial cells. J Cell Physiol 2005, 204:881-888.
63. Im S.S., Yousef L., Blaschitz C., Liu J.Z., Edwards R.A., Young S.G., et al. Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab 2011, 13:540-549.
64. Joseph S.B., Bradley M.N., Castrillo A., Bruhn K.W., Mak P.A., Pei L., et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 2004, 119:299-309.
65. Posokhova E.N., Khoshchenko O.M., Chasovskikh M.I., Pivovarova E.N., Dushkin M.I. Lipid synthesis in macrophages during inflammation in vivo: effect of agonists of peroxisome proliferator activated receptors alpha and gamma and of retinoid X receptors. Biochem Biokhim 2008, 73:296-304.
66. Franchi L., Eigenbrod T., Munoz-Planillo R., Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009, 10:241-247.
67. Zelcer N., Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 2006, 116:607-614.
68. Tangirala R.K., Bischoff E.D., Joseph S.B., Wagner B.L., Walczak R., Laffitte B.A., et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci U S A 2002, 99:11896-11901.
69. Hong C., Walczak R., Dhamko H., Bradley M.N., Marathe C., Boyadjian R., et al. Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: identification of ARL7 as a direct target. J Lipid Res 2011, 52:531-539.
70. Ghisletti S., Huang W., Jepsen K., Benner C., Hardiman G., Rosenfeld M.G., et al. Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Genes Dev 2009, 23:681-693.
71. Spann N.J., Glass C.K. Sterols and oxysterols in immune cell function. Nat Immunol 2013, 14:893-900.
72. Mihaylova M.M., Shaw R.J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 2011, 13:1016-1023.
73. Galic S., Fullerton M.D., Schertzer J.D., Sikkema S., Marcinko K., Walkley C.R., et al. Hematopoietic AMPK beta1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J Clin Invest 2011, 121:4903-4915.
74. Namgaladze D., Lips S., Leiker T.J., Murphy R.C., Ekroos K., Ferreiros N., et al. Inhibition of macrophage fatty acid beta-oxidation exacerbates palmitate-induced inflammatory and endoplasmic reticulum stress responses. Diabetologia 2014, 57:1067-1077.
75. Fullerton M.D., Steinberg G.R., Schertzer J.D. Immunometabolism of AMPK in insulin resistance and atherosclerosis. Mol Cell Endocrinol 2013, 366:224-234.
76. Fullerton M.D., Ford R.J., McGregor C.P., LeBlond N.D., Snider S.A., Stypa S.A., et al. Salicylate improves macrophage cholesterol homeostasis via activation of Ampk. J Lipid Res 2015, 56:1025-1033.
77. Sag D., Carling D., Stout R.D., Suttles J. Adenosine 5'-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 2008, 181:8633-8641.
78. Miao H., Ou J., Ma Y., Guo F., Yang Z., Wiggins M., et al. Macrophage CGI-58 deficiency activates ROS-inflammasome pathway to promote insulin resistance in mice. Cell Rep 2014, 7:223-235.
79. Lawlor K.E., Vince J.E. Ambiguities in NLRP3 inflammasome regulation: is there a role for mitochondria?. Biochim Biophys Acta 1840, 2014:1433-1440.
80. DeBerardinis R.J., Lum J.J., Hatzivassiliou G., Thompson C.B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008, 7:11-20.
81. Kidani Y., Elsaesser H., Hock M.B., Vergnes L., Williams K.J., Argus J.P., et al. Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nat Immunol 2013, 14:489-499.
82. Barbi J., Pardoll D., Pan F. Metabolic control of the Treg/Th17 axis. Immunol Rev 2013, 252:52-77.
83. Lee J., Walsh M.C., Hoehn K.L., James D.E., Wherry E.J., Choi Y. Regulator of fatty acid metabolism, acetyl coenzyme a carboxylase 1, controls T cell immunity. J Immunol 2014, 192:3190-3199.
84. Bensinger S.J., Bradley M.N., Joseph S.B., Zelcer N., Janssen E.M., Hausner M.A., et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 2008, 134:97-111.
85. Geyeregger R., Shehata M., Zeyda M., Kiefer F.W., Stuhlmeier K.M., Porpaczy E., et al. Liver X receptors interfere with cytokine-induced proliferation and cell survival in normal and leukemic lymphocytes. J Leukoc Biol 2009, 86:1039-1048.
86. Berod L., Friedrich C., Nandan A., Freitag J., Hagemann S., Harmrolfs K., et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med 2014, 20:1327-1333.